Female Signs and Symptoms of Myocardial Infarction
Chest pain remains the predominant symptom in women with MI, occurring with equal frequency as in men (87-92%), but women are significantly more likely to present with accompanying symptoms including nausea, shortness of breath, fatigue, jaw/neck pain, and diaphoresis. 1, 2, 3
Primary Symptom Presentation
- Chest pain/discomfort is reported by 87-92% of women with MI, described as retrosternal pressure, tightness, heaviness, squeezing, crushing, cramping, burning, or aching sensation that builds gradually over several minutes 1, 2, 4
- The chest pain radiates to the neck, jaw, shoulders, back, or one or both arms in the majority of cases 2, 3
- Women with MI are more likely to present with "typical" symptoms than men (77% vs 59%) when using standardized diagnostic criteria 1, 4
Accompanying Symptoms More Common in Women
Women are significantly more likely than men to experience these additional symptoms alongside or instead of chest pain:
- Shortness of breath occurs in 53-59% of women with MI 1, 5
- Unusual fatigue is reported by 59-70% of women, often as a prodromal symptom in the days preceding MI 1, 5
- Nausea and vomiting are more common in women than men 1
- Epigastric discomfort and unexplained indigestion or belching occur more frequently in women 1, 2
- Diaphoresis (sweating) is significantly more common in women 2, 3
- Pain in jaw, neck, arms, or between shoulder blades occurs in 61.9% of women versus 54.8% of men aged ≤55 years 1, 2, 3
- Upper back/shoulder blade pain is reported by 42-47% of women 1, 5
- Palpitations are more common in women 1, 2
Prodromal Symptoms
- 68-90% of women experience prodromal symptoms in the days or weeks before MI, most commonly unusual fatigue (70%), shortness of breath (53%), and upper back/shoulder blade pain (47%) 5
- Women's ischemic symptoms are more often precipitated by mental or emotional stress and less frequently by physical exertion compared to men 1
High-Risk Populations Requiring Heightened Awareness
Women with Diabetes
- Diabetes is a stronger risk factor for MI in women than in men 2, 3
- Women with diabetes may present with atypical symptoms due to autonomic dysfunction 1, 2, 3
Elderly Women (>75 years)
- May present with generalized weakness, confusion, mental status changes, syncope, acute delirium, or unexplained falls rather than classic chest pain 1, 2, 3
- In patients >75 years with chest pain, ACS should be considered when accompanying symptoms such as shortness of breath, syncope, or acute delirium are present 1
Younger Women (≤55 years)
- Are equally likely as men to present with chest pain (87% vs 89.5%) but more likely to report associated symptoms (61.9% vs 54.8%) 1
Critical Clinical Pitfalls to Avoid
- Traditional risk assessment tools and physician clinical judgment consistently underestimate cardiac risk in women and misclassify their symptoms as nonischemic chest pain 1, 2, 3
- Women are less likely to receive timely and appropriate care despite similar or higher symptom burden 1, 2
- Never dismiss accompanying symptoms (nausea, fatigue, shortness of breath, jaw/neck pain) as non-cardiac when they occur with or without chest discomfort 2, 3
- Up to 30% of women with STEMI present with atypical symptoms, leading to delayed presentation and treatment 1
- Women present later to medical care than men, often because prodromal symptoms are not recognized as cardiac in origin 1, 5
Pathophysiologic Differences Explaining Symptom Patterns
- Women have a higher proportion of MI caused by mechanisms other than classical plaque rupture, including plaque erosion, coronary microvascular dysfunction, coronary vasospasm, spontaneous coronary artery dissection, and stress-related (Takotsubo) cardiomyopathy 2
- Women more often have nonobstructive CAD (1-49% stenosis) at angiography despite symptomatic ischemia, with elevated hazard for coronary events particularly in women <75 years 1
- Myocardial ischemia is associated with higher IHD mortality among symptomatic women than among men 1
Immediate Diagnostic Approach
- Any woman presenting with chest discomfort plus accompanying symptoms (especially shortness of breath, nausea, jaw/neck pain, or diaphoresis) requires immediate 12-lead ECG within 10 minutes and cardiac biomarker assessment 2, 3
- Place patient in environment with continuous ECG monitoring and defibrillation capability 1
- Use high-sensitivity cardiac troponin with sex-specific thresholds (>16 ng/L for women vs >34 ng/L for men) to avoid missing MI in women 4
- Assess cardiovascular risk factors including age, hypertension, hyperlipidemia, diabetes, family history of premature CAD, and sedentary lifestyle—all more prevalent in women presenting with suspected ACS 1
Treatment Considerations
- Women derive equal benefit from aspirin, clopidogrel, anticoagulants, beta blockers, ACE inhibitors, statins, and GP IIb/IIIa antagonists (when troponin elevated) as men 1
- Women are at increased risk of bleeding complications, requiring careful attention to dosing of antiplatelet and anticoagulant agents based on estimated creatinine clearance rather than serum creatinine alone 1
- Use low-dose aspirin (75-162 mg) to reduce excess bleeding risk, especially in combination with clopidogrel 1
- Women and men receive equal benefit from reperfusion strategies and should be managed identically 1